申请人:Sterling Drug Inc.
公开号:US05017584A1
公开(公告)日:1991-05-21
2-(4,5-Dihydro-1H-imidazol-2-yl)-2,3-dihydro-1H-indoles, 2-(4,5-dihydro-1H-imidazol-2-yl)-1,2,3,4-tetrahydroquinolines and 2-(4,5-dihydro-1H-imidazol-2-yl)-1H-indoles, useful as antidepressant agents, are prepared by reacting a respective lower-alkyl 2,3-dihydro-1H-indole-2-carboxylate 1,2,3,4-tetrahydroquinoline-2-carboxylate or 1H-indole-2-carboxylate derivative with ethylenediamine or an N-lower-alkylethylenediamine in the presence of a Lewis-type acid.
2-(4,5-二氢-1H-咪唑-2-基)-2,3-二氢-1H-吲哚,2-(4,5-二氢-1H-咪唑-2-基)-1,2,3,4-四氢喹啉和2-(4,5-二氢-1H-咪唑-2-基)-1H-吲哚,作为抗抑郁剂有用,通过将相应的低烷基2,3-二氢-1H-吲哚-2-羧酸酯,1,2,3,4-四氢喹啉-2-羧酸酯或1H-吲哚-2-羧酸酯衍生物与乙二胺或N-低烷基乙二胺在Lewis型酸存在下反应制备。